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Research article 
Ερευνητικό άρθρο 
Clinical, clinicopathological and diagnostic imaging findings in 14 dogs 
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Κλινικά, εργαστηριακά και απεικονιστικά ευρήματα σε 14 σκύλους 
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ABSTRACT. Fibrocartilaginous embolic myelopathy was diagnosed in 14 dogs with acute neurological dysfunction, based 
on history, findings of clinical examination, diagnostic imaging evaluation, follow-up and outcome. The dogs were presented 
with signs of variable involvement of the spinal cord, which were lateralized in 4 cases. The initial clinicopathological 
evaluation was unremarkable, while cerebrospinal fluid analysis was abnormal in one dog. Diagnostic imaging investigation 
(plain radiographs of the spinal column and myelography) did not reveal any abnormalities in the vertebrae and adjacent 
tissues or compression of the spinal cord, with the exception of one case, where there was evidence of focal intramedullary 
oedema corresponding to the lesion location. Seven dogs improved significantly with supportive treatment; complete 
remission of clinical signs was evident in two. Moderate improvement was seen in three animals and minimal or no 
improvement in four dogs, which were euthanised due to persisting neurological incapacitation. 
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ΠΕΡΙΛΗΨΗ. Η παρούσα μελέτη αφορά στην αναδρομική αξιολόγηση 14 σκύλων με ισχαιμική μυελοπάθεια από ινοχόν-
δρινα έμβολα. Η επιλογή των ζώων έγινε με βάση το ιστορικό, τα ευρήματα της κλινικής, εργαστηριακής και απεικονιστικής 
διερεύνησης, την εξέλιξη και την τελική έκβαση των περιστατικών. Όλοι οι σκύλοι προσκομίστηκαν στην Κλινική Ζώων 
Συντροφιάς της Κτηνιατρικής Σχολής του ΑΠΘ, επειδή εμφάνισαν απότομα (σε διάστημα 6-24 ωρών) διάφορης έκτασης 
πάρεση ή παράλυση. Η εκδήλωση των συμπτωμάτων ήταν ασύμμετρη σε τέσσερα ζώα και συμμετρική στα υπόλοιπα. Από την 
αιματολογική εξέταση, τη βιοχημική εξέταση του ορού, την ανάλυση του ούρου και του εγκεφαλονωτιαίου υγρού δεν προέ­
κυψαν παθολογικά ευρήματα. Στην ακτινολογική εξέταση της σπονδυλικής στήλης δεν παρατηρήθηκαν αξιόλογα ευρήματα, 
με εξαίρεση ένα ζώο, στο οποίο διαπιστώθηκε η παρουσία διαμαρτιών διάπλασης σε ορισμένους θωρακικούς σπόνδυλους. 
Σε όλους τους σκύλους, πραγματοποιήθηκε μυελογραφία, από την οποία, σε καμία περίπτωση, δεν προέκυψαν ευρήματα 
συμβατά με συμπιεστική μυελοπάθεια, αλλά σε ένα περιστατικό υπήρξαν ενδείξεις εντοπισμένου ενδομυελικού οιδήματος 
στην οσφυϊκή μοίρα του νωτιαίου μυελού. Η θεραπευτική αντιμετώπιση ήταν μόνο συμπτωματική και υποστηρικτική σε 
όλα τα ζώα. Επτά σκύλοι παρουσίασαν σημαντική βελτίωση της κλινικής εικόνας ή και πλήρη ίαση, ενώ μερική ή καμία 
βελτίωση των συμπτωμάτων διαπιστώθηκε σε τρία και τέσσερα ζώα, αντίστοιχα. Στα τελευταία έλαβε χώρα ευθανασία, 
λόγω της βαρύτητας των νευρολογικών τους διαταραχών. 
Λέξεις ευρετηρίασης: ινοχόνδρινα έμβολα, ισχαιμική μυελοπάθεια, σκύλος 
INTRODUCTION 
Fibrocartilaginous embolic myelopathy (FCEM) has been described in several animal species 
(dogs, cats, ruminants, pigs, horses), as well as in 
humans (De Risio and Piatt, 2010). It is a vascular 
myelopathy, attributed to the occlusion of arterial 
and/or venous supply to a specific region of the spinal 
cord by fibrocartilaginous material histologically and 
histochemically identical to the nucleus pulposus of 
intervertebral discs (Sharp and Wheeler, 2005). Sev­
eral theories regarding the potential pathophysiology 
of fibrocartilaginous embolic myelopathy have been 
proposed, although the mechanism by which fibrocar­
tilaginous material reaches the spinal cord vasculature 
still remains unknown. Hypotheses proposed include 
the direct penetration of nucleus pulposus fragments 
into the spinal cord vessels (possibly associated with 
increased intrathoracic and intraabdominal pressure) 
(Gilmore and de Lahunta, 1986), chronic inflammatory 
neovascularisation of degenerated intervertebral disks 
(Hayes et al., 1978), presence of embryonic remnant 
vessels within the nucleus pulposus (Hayes et al., 1978) 
and mechanical herniation of nucleus pulposus into 
the vertebral bone marrow (Olby and Jeffery, 2003). 
Initially fibrocartilaginous embolic myelopathy was 
thought to affect animals of large and giant breeds, 
however there have been several reports of cases in 
small as well as in chondrodystrophic breeds (Gandini 
et al., 2003; Grunenfelder et al., 2005). 
Affected dogs are typically presented with a history 
of peracute to acute onset of clinical signs, progressing 
within a period of two to four hours. The degree of 
neurological dysfunction depends on localization and 
severity of the spinal cord ischemic injury. The major­
ity of patients present signs of a non-progressive, non-
painful and often asymmetric myelopathy, most com­
monly affecting the cervicothoracic (C8-T2) or lum­
bosacral (L4-S3) spinal cord segments (Gilmore and de 
Lahunta, 1986; Gandini et al., 2003). The differential 
diagnosis includes other causes of embolic myelopathy 
(bacterial and parasitic diseases, neoplasia), underlying 
medical conditions predisposing to embolisation or 
thrombosis (hypo- or hyperthyroidism, hyperadreno-
corticism, cardiomyopathy, hypertension, chronic renal 
failure), traumatic and compressive intervertebral disk 
extrusion, focal myelitis and intra- or extramedullary 
haemorrhage. Ante-mortem diagnosis is supported by 
history and exclusion of the various aforementioned 
conditions, with the aid of clinical and clinicopatho-
logical assessment and advanced diagnostic imaging 
(Dewey, 2008; De Risio and Piatt, 2010). 
The aim of this retrospective case series is to 
present the clinical, clinicopathological and diagnostic 
imaging findings, as well as the follow-up and final 
outcome of 14 dogs with suspected fibrocartilaginous 
embolic myelopathy. 
MATERIALS AND METHODS 
A total of 14 dogs presented with the main com­
plaint of acute, non-progressive ataxia, paresis or 
paralysis were included in the study. Data recorded 
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Table 1. Details, clinical and diagnostic imaging findings in 14 dogs with suspected fibrocartilaginous embolic myelopathy. 
Case Age „ , „ Duration of signs Location 
,
 &
 x
 Breed Gender η. \ π • 
no. (years) (hours) of lesions 
Prior Lateralization Findings in spinal Findings in 
exercise of signs radiography myelography 
9 
10 
11 
12 
13 
14 
3.5 
2 
2.5 
8.5 
5.5 
9 
10 
5 
3 
11 
3.5 
6.5 
Gekas 
German 
shepherd 
Poodle 
Rottweiler 
German 
shepherd 
Siberian 
husky 
Rottweiler 
Labrador 
retriever 
French 
bulldog 
Mixed breed 
French 
bulldog 
English setter 
Gekas 
Yorkshire 
terrier 
M 
M 24 
M 
M 
F 
F 
F 
M 
M 
M 
M 
F 
F 
12 
24 
6 
24 
24 
6 
24 
24 
6 
24 
6 
Thoraco-lumbar 
(T3-L3) 
Cervico-thoracic 
(C6-T2) 
Thoraco-lumbar 
(T3-L3) 
Thoraco-lumbar 
(T3-L3) 
Thoraco-lumbar 
(T3-L3) 
Thoraco-lumbar 
(T3-L3), spinal 
hyperaesthesia 
Cervico-thoracic 
(C6-T2) 
Cervico-thoracic 
(C6-T2) 
Thoraco-lumbar 
(T3-L3) 
Lumbosacral 
(L4-S3) 
Lumbosacral 
(L4-S3) 
Cervicothoracic 
(C6-T2) 
Cervicothoracic 
(C6-T2) 
Cervicothoracic 
(C6-T2) 
Yes 
No 
Yes 
No 
No 
Yes 
No 
Yes 
No 
No 
No 
Yes 
Yes 
Yes 
No 
Yes (R) 
No 
No 
No 
No 
Yes (R) 
Yes (R) 
No 
No 
No 
No 
No 
Yes (R) 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
Spondylosis deformans 
of the lumbosacral joint 
WNL 
Multiple congenital 
vertebral abnormalities 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
Spinal cord 
swelling 
(L1-L2) 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
WNL 
M: male, F: female, L: left, R: right, WNL: within normal limits. 
in all dogs included information concerning the onset 
and progression of signs, previous medical treatments, 
presence or absence of spinal pain, severity of insult 
(paresis/plegia, presence/absence of deep pain sensa­
tion), symmetry of neurological signs, neuroanatomic 
lesion localization. The degree of spinal cord dysfunc­
tion was scored using a scale of 0 to 5 (Sharp and 
Wheeler, 2005). In all cases, spinal cord trauma had 
been excluded from the differential diagnosis based on 
history and initial clinical evaluation. 
Clinicopathological tests carried out in all cases 
included a complete blood cell count, serum biochem­
istry profile (total proteins, albumin, glucose, choles­
terol, triglycerides, urea nitrogen, creatinine, alkaline 
phosphatase, alanine aminotransferase, calcium, phos­
phorus, sodium and potassium) and urinalysis. Cerebro­
spinal fluid analysis, performed in all dogs in samples 
collected prior to myelography, included macroscopic 
evaluation, total and differential cell counts and meas­
urement of albumin concentration. 
Diagnostic imaging evaluation was performed in 
all dogs under general anesthesia and included survey 
radiographs of the spinal column and cisternal myelog­
raphy. The latter procedure was performed within two 
days of the initial presentation and examination of 
patients. 
Physical therapy procedures to be performed by 
the owners of the animals were initiated after estab­
lishment of diagnosis and was modified according to 
the daily routine programme and competence of the 
owners. It included passive manipulation and massage 
of the affected limbs, support of severely incapacitated 
animals in the standing position and frequent changes 
of posture (lateral to sternal recumbency). Provision 
of further standard supportive treatment for recumbent 
animals (assisted feeding and drinking, soft bedding, 
cleanliness) was also advised (Sharp and Wheeler, 
2005). 
Follow up of the cases was performed by re-exam­
ination of the patients. 
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Table 2. Follow-up and outcome in 14 dogs with suspected fibrocartilaginous embolic myelopathy 
Case 
no. 
Neurological signs Duration of follow-up Outcome 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Acute paraplegia (grade IV) 
Acute right thoracic limb monoparesis —> tetraplegia (grade 
IV) 
Acute paraparesis —> paraplegia (grade V) 
Acute paraparesis (grade III) 
Acute paraparesis (grade III) 
Acute paraplegia (grade IV) 
Acute right thoracic limb monoparesis —* tetraparesis (grade 
III) 
Acute tetraraparesis (grade III) 
Acute paraplegia (grade IV) 
Acute paraparesis (grade IV) 
Acute paraplegia (grade V) 
Acute tetraparesis —> tetraplegia (grade IV) 
Acute tetraplegia (grade IV) 
Acute right-sided hemiparesis —> hemiplegia 
2 months 
1 month 
2 months 
1.5 months 
1 month 
2 weeks 
1 month 
1 month 
2 months 
3 months 
2 weeks 
6 months 
2 months 
2 months 
Significant improvement, first noted after 1 month 
Significant improvement, first noted after 10 days 
Significant improvement, first noted after 1 month 
Moderate improvement, first noted after 20 days 
Moderate improvement, first noted after 10 days 
No improvement, euthanasia 
No improvement, euthanasia due to concurrent 
medical problems 
Moderate improvement, first noted after 15 days 
Significant improvement, first noted after 15 days 
Significant improvement, first noted after 1.5 months 
No improvement, euthanasia 
Significant improvement, first noted after 15 days; 
normal after 1 month 
Minimal improvement, euthanasia 
Significant improvement, first noted after 15 days; 
normal after 2 months 
RESULTS 
All dogs were adults and their age ranged from 
2 to 11 years. Regarding their sex and breed, 8 were 
male and 6 female, 13 were pure-breds and one was 
a mixed breed (Table 1). All dogs were presented for 
evaluation because of acute or peracute paresis or 
paralysis of one or more limbs. Physical exercise of 
variable intensity prior to the appearance of signs was 
reported in 7 dogs. Eight dogs were presented with 
acute paraparesis (3/8) or paraplegia (5/8), five with 
tetraparesis (2/5) or tetraplegia (3/5) and one with 
right sided hemiparesis that progressed to hemiplegia. 
Lateralization of neurological signs was observed in 
four dogs, two of which initially had been presented 
with paresis of the right thoracic limb and subsequently 
asymmetric tetraparesis or tetraplegia. The remaining 
two animals exhibited right sided hemiparesis or asym­
metric tetraparesis (Table 2). 
No abnormalities were detected in routine clin-
icopathological evaluation (complete blood count, 
serum biochemistry and urinalysis). Cerebrospinal fluid 
analysis revealed mild (25 nucleated cells/μΐ) pleocyto-
sis in one dog. Radiographic examination of the spine 
revealed presence of congenital vertebral anomalies in 
one animal and mild spondylosis deformans of the lum­
bosacral joint in another (Table 1). Cisternal myelogra­
phy did not show spinal cord compression at the sites 
corresponding to the neurological lesion localization. 
In one animals, there was evidence of focal spinal cord 
oedema involving the LI and L2 segments. 
Follow up of patients ranged from two weeks to six 
months. Significant improvement or complete remis­
sion of signs (regarding ambulation) was noted in seven 
dogs. In these patients, the first signs of improvement 
were noted within 10 to 20 days. In three animals, 
improvement was considered to be moderate and in 
the remaining four as minimal or absent (Table 2). In 
these four dogs, euthanasia was finally performed, due 
to their poor response to conservative treatment. 
DISCUSSION 
Initially reported principally in large sized dogs, 
fibrocartilaginous embolic myelopathy is now consid­
ered a disease that may affect all breeds. Although the 
large and giant breeds of dogs still represent a signifi­
cant proportion of animals reported in many relevant 
publications (Gandini et al., 2003), smaller breeds, 
as well as mixed breed dogs, may also be affected 
(Nakamoto et al., 2008, De Risio and Platt, 2010), in 
some studies even outnumbering larger size animals 
(Nakamoto et al., 2008, Nakamoto et al., 2009). In 
the present study, six dogs were of large breed, whilst 
four were medium- and four small-sized dogs (Table 
1). Two dogs belonged to a chondrodystrophic breed 
(French bulldog) and seven other to breeds reported 
to be predisposed to degenerative intervertebral disk 
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disease, either small (Poodle, Yorkshire terrier) or 
large-sized (German shepherd, Rottweiler, Labrador 
retriever) (Table 1) (Olby, 2004; Brisson, 2010). 
The age range of the study population (2-11 years) 
is in agreement with that reported in the literature 
(Cauzinille and Kornegay, 1997; Gandini et al, 2003, 
De Risio et al., 2008). Nearly half of the animals 
included in the study (6/14) were young adults (less 
than 5 year-old). Similarly, male and female dogs were 
almost equally represented (Table 1). Reported male 
to female ratios vary from 1:1 to 2.5:1 (Cauzinille and 
Kornegay, 1996; Gandini et al., 2003; De Risio et al., 
2008; De Risio and Platt, 2010). 
Patients with fibrocartilaginous embolic myelopa­
thy are typically presented with a history of peracute 
to acute onset and progression of clinical signs, which 
is valuable information for the differential diagnosis. 
Most dogs reach the peak severity of neurological 
dysfunction within 24 hours, many within 6 hours or 
less, as was observed in the present study (Table 1) 
(Olby, 2004; Dewey, 2008). Owners often observe the 
affected dog to cry out in apparent pain during exercise 
shortly before the onset of neurological dysfunction 
(Sharp and Wheeler, 2005; De Risio and Piatt, 2010). 
These dogs are often not in any detectable pain by the 
time they are presented to the clinician, as had been 
observed in all but one of our cases. The incidence of 
spinal hyperesthesia varies from 12 to 50% (Cauzinille 
and Kornegay, 1996; Gandini et al., 2003). Pain was 
reported in only one dog, which had developed pera­
cute paraparesis and paraplegia while attempting to 
defecate. Increased intra-abdominal pressure during 
straining or exercise (Valsalva's manoeuver), potential­
ly causing retrograde propulsion of nucleus pulposus 
material into the spinal vasculature, has been proposed 
as one of the pathomechanisms for fibrocartilaginous 
embolic myelopathy (De Risio and Piatt, 2010). 
Clinical signs in fibrocartilaginous embolic mye­
lopathy vary depending upon location and severity of 
the spinal cord ischemic injury. The cervicothoracic 
(C5-T2) and lumbosacral (L4-S3) spinal cord segments 
are most commonly affected, with reported frequencies 
of 30 to 33% and 43 to 47%, respectively (Cauzinille 
and Kornegay, 1996; Gandini et al., 2003; De Risio et 
al., 2007). In the study population of the series reported 
here, almost half of the animals involved (6/14) showed 
signs of cervicothoracic syndrome. Conversely, the 
lumbosacral syndrome was noted only in two dogs. 
The remaining dogs were presented with thoracolum­
bar (T3-L3) spinal cord dysfunction, which has been 
reported less frequently in some studies (De Risio and 
Piatt, 2010). In contrast, thoracolumbar syndrome has 
been noted as the most frequent neurolocalization in 
fibrocartilaginous embolic myelopathy in other clini­
cal studies (Nakano et al., 2008; Nakano et al., 2009). 
Asymmetry of clinical signs, an important and common 
feature of fibrocartilaginous embolic myelopathy, was 
observed in four of the animals with cervicothoracic 
syndrome, initially mimicking orthopaedic diseases 
causing lameness (Sharp and Wheeler, 2005; Dewey, 
2008). These dogs were submitted for examination 
very soon after the onset of signs (within 6-24 hours), 
compared to the rest of the patients, in which the lack 
of lateralization symptoms could be attributed to their 
delayed referral or to the more extensive involvement 
of the spinal cord. With the exception of secondary 
spinal cord injury, neurological deterioration in fibro­
cartilaginous embolic myelopathy rarely progresses for 
over 24 hours (Dewey, 2008; De Risio and Piatt, 2010). 
Diagnosis of the disorder is based on history, 
clinical signs and by ruling out other causes of acute 
myelopathy. Other causes of acute and potentially 
asymmetrical spinal cord dysfunction include acute 
compressive (Olby, 2004; Dewey, 2008) and non­
compressive intervertebral disk extrusion (Chang et 
al., 2007; De Risio et al., 2009; Brisson, 2010), acute 
focal myelitis, embolisation or thrombosis secondary 
to other systemic disorders (cardiomyopathy, coagu­
lopathies, hypothyroidism, chronic renal failure) (De 
Risio and Piatt, 2010). From a clinical point of view, 
spinal hyperaesthesia is common in acute intervertebral 
disk extrusion and the main clinical sign differentiating 
it from fibrocartilaginous embolic myelopathy, which 
is non-painful (De Risio and Piatt, 2010). Most of the 
other diagnostic differentials, predisposing to emboli­
zation or thrombosis, are either identified or excluded 
during clinical, clinicopathologic (complete blood 
cell count, serum biochemical evaluation, urinalysis) 
and cerebrospinal fluid analysis, which had been per­
formed in all the cases described, yielding unremark­
able results. Cerebrospinal fluid analysis has been 
reported to offer low sensitivity in fibrocartilaginous 
embolic myelopathy, rather than excluding myelitis. 
Plain radiographs of the spine aim to ruling out 
traumatic spinal injuries and diskospondylitis. In one 
animal, congenital anomalies (hemivertebrae) were 
J HELLENIC VET MED SOC 2012,63(3) 
ΠΕΚΕ 2012,63(3) 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/02/2020 07:26:48 |
198 POLIZOPOULOU Z.S., KARNEZID., KARNEZIG. 
identified in the cranial thoracic (T1-T4) vertebrae; 
however, their presence was asymptomatic, as no 
spinal cord compression was observed during contrast 
studies. Congenital vertebral anomalies are a common 
finding in French bulldogs, although their clinical 
course varies considerably from asymptomatic disease 
to severe compressive myelopathy (Westworth and 
Sturges, 2010). Myelography is used for excluding 
compressive myelopathies and offers the additional 
advantage of cerebrospinal fluid collection for analysis. 
Patients with fibrocartilaginous embolic myelopathy 
may show an intramedullary pattern, associated with 
spinal cord swelling around the embolised region, or 
have normal findings in myelography (Nakamoto et al., 
2008; Nakamoto et al., 2009). In this study, myelogra­
phy was performed in all cases and indicated no spinal 
cord compression. However, in one animal there was 
evidence of focal intramedullary oedema, compatible 
with the neuroanatomical lesion localisation. This dog 
had been referred immediately after onset of clinical 
signs and myelography had been performed within 24 
hours. In contrast, in another animal, also peracutely 
affected and immediately submitted for evaluation, 
no similar findings were noted (Table 1). Acute non­
compressive intervertebral disk extrusion, which is a 
possible diagnosis in cases of peracute myelopathy, 
has been reported to be suspected when there was evi­
dence of spinal cord oedema located over a collapsed 
disk space combined with persisting spinal pain for 
more than 24 hours (Brisson, 2010; De Risio and Piatt, 
2010). Moreover, accuracy of myelography in diagnos­
ing peracute compressive myelopathy secondary to 
intervertebral disk extrusion is reported to range from 
72 to 97% (Brisson, 2010). 
The preferred diagnostic imaging procedure for 
fibrocartilaginous embolic myelopathy diagnosis is 
magnetic resonance imaging. Advantages include the 
exclusion of other differential diagnostic possibili­
ties and the identification of signal intensity changes 
associated with vascular infarction (Nakamoto et al., 
2008; Nakamoto et al., 2009). Unfortunately, although 
magnetic resonance imaging had been proposed as a 
diagnostic test in all dogs studied, it had been rejected 
by their owners for financial reasons. 
The clinical value of glucocorticoid treatment in 
fibrocartilaginous embolic myelopathy is questionable, 
especially when administered in recumbent patients 
susceptible to a variety of secondary complications 
(Dewey, 2008; De Risio and Piatt, 2010). Physical 
therapy and good nursing care are part of the preferred 
treatment regime, which should begin as soon as possi­
ble and be protracted, as duration has a positive impact 
on neurological recovery (Sharp and Wheeler, 2005; 
Dewey, 2008). In addition, the absence of surgical 
wounds and pain allow its application immediately 
and without restrictions in fibrocartilaginous embolic 
myelopathy patients. Reported rehabilitation rates 
vary in published studies, possibly reflecting the non-
homogeneous study populations and handling of cases 
(Gandini et al., 2003; De Risio et al., 2008). 
Prognosis of fibrocartilaginous embolic myelopa­
thy is variable, depending on location of lesions and 
severity of ischaemia. Recovery rates ranging from 
58 to 84% have been reported (De Risio et al., 2007; 
Dewey, 2008). The prognosis is good for dogs that 
regain functional status within the first two weeks 
of spinal cord injury. Lesions affecting the cervicot-
horacic (C6-T2) and the lumbosacral (L4-S3) spinal 
cord segments bear a worse prognosis due to the 
involvement of lower motor neurons (Dewey, 2008; 
De Risio and Piatt, 2010). In the present study, of six 
dogs with lesion localization in the aforementioned 
areas, four eventually showed significant or moderate 
improvement rendering them functional as pets (Table 
2). Other negative prognostic factors are loss of deep 
pain sensation, urine and/or faecal incontinence (De 
Risio and Piatt, 2010). One of the two dogs of our study 
with grade V spinal cord dysfunction and evidence of 
intramedullary oedema improved significantly after one 
month, while the other remained severely incapacitated 
and was euthanised. 
Concluding remarks 
Despite its acute onset and severely debilitating 
clinical presentation, fibrocartilaginous embolic mye­
lopathy is a disease with potentially favourable prog­
nosis. Thorough clinical and clinicopathological diag­
nostic work, combined with application of myelogra­
phy, is important for establishing aetiological diagno­
sis, prognosis and treatment outline. S 
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